Skip to main content
. 2017 Mar 28;24(7):1761–1769. doi: 10.1245/s10434-017-5820-8

Table 2.

Baseline, surgical and histopathologic characteristics of 2077 patients treated with primary gastrectomy for cancer

Characteristic All (N = 2077) <5 weeks (n = 772) 5–8 weeks (n = 727) >8 weeks (n = 578) p
n (%) n (%) n (%) n (%)
Baseline characteristics
 Age, year, mean (±SD) 73.5 (±10.1) 73.2 (10.4) 74.6 (8.9) 72.3 (11.1) <0.001
 Gender 0.345
  Male 1253 (60) 461 (37) 429 (34) 363 (29)
  Female 824 (40) 311 (38) 298 (36) 215 (26)
 Malignancy history 0.393
  No 1745 (84) 659 (38) 608 (35) 478 (27)
  Yes 332 (16) 113 (34) 119 (36) 100 (30)
 Tumor differentiation 0.008
  Good to moderate 582 (34) 212 (31) 197 (33) 173 (40)
  Poor to undifferentiated 1131 (66) 467 (69) 404 (67) 260 (60)
  Missing 364 93 126 145
 cT stage <0.001
  T1 139 (19) 24 (17) 37 (27) 78 (56)
  T2 347 (48) 120 (35) 133 (38) 94 (27)
  T3 150 (21) 57 (38) 50 (33) 43 (29)
  T4a 84 (12) 45 (54) 24 (29) 15 (18)
  Tx 1357 526 483 348
 cN stage <0.001
  N0 1326 (77) 440 (33) 483 (36) 403 (30)
  N+ 387 (23) 181 (47) 136 (35) 70 (18)
  Nx 364 151 108 105
 Year of diagnosis <0.001
  2006–2008 934 (45) 426 (46) 308 (33) 200 (21)
  2009–2011 608 (29) 187 (31) 220 (36) 201 (33)
  2012–2014 535 (26) 159 (30) 199 (37) 177 (33)
 Referral status <0.001
  Diagnosis in treatment hospital 1657 (86) 674 (41) 585 (35) 398 (24)
  Diagnosis in other hospital 262 (14) 60 (23) 81 (31) 121 (46)
  Missing 158 38 61 59
Treatment and histopathologic characteristics
 Surgical type 0.008
  Distal gastrectomy 1435 (69) 545 (38) 501 (35) 389 (27)
  Total gastrectomy 607 (29) 206 (34) 215 (35) 186 (31)
  Multiorgan surgery 35 (2) 21 (60) 11 (31) 3 (9)
 Surgical approach 0.002
  Open 1908 (94) 728 (38) 671 (35) 509 (27)
  Laparoscopic 129 (6) 33 (26) 45 (35) 51 (40)
  Missing 40 11 11 18
 Radicality 0.003
  R0 1689 (85) 595 (35) 599 (35) 495 (29)
  R1–2 291 (15) 126 (43) 106 (36) 59 (20)
  Rx 97 51 22 24
 pT stage <0.001
  T1 454 (22) 89 (20) 156 (34) 209 (46)
  T2 321 (16) 104 (32) 121 (38) 96 (30)
  T3 747 (36) 321 (43) 259 (35) 167 (22)
  T4a 489 (24) 234 (48) 166 (34) 89 (18)
  T4b 55 (3) 23 (42) 21 (38) 11 (20)
  Tx 11 1 4 6 <0.001
 pN stage
  N0 995 (48) 291 (29) 346 (35) 358 (36)
  N1 347 (17) 137 (39) 127 (37) 83 (24)
  N2 336 (16) 146 (43) 121 (36) 69 (21)
  N3 390 (19) 193 (49) 130 (33) 67 (17)
  Nx 9 5 3 1
 pM stage 0.162
  M0 2003 (96) 737 (37) 707 (35) 559 (28)
  M1 74 (4) 35 (47) 20 (27) 19 (26)
 Curative intent 0.035
  Yes 1946 (94) 713 (37) 687 (35) 546 (28)
  No 120 (6) 58 (48) 36 (30) 26 (22)
  Missing 11 1 4 6
 90-day mortality 240 (12) 94 (12) 68 (9) 78 (13) 0.053
 Adjuvant therapy 0.043
  No 1993 (96) 730 (37) 704 (35) 559 (28)
  Chemotherapy 28 (1) 11 (39) 6 (21) 11 (39)
  Radiotherapy 1 (<1) 1 (100) 0 (0) 0 (0)
  Chemoradiation 55 (3) 30 (55) 17 (31) 8 (15)